Standard Contracts
RECITALSLicensing and Distribution Agreement • December 8th, 2006 • uWink, Inc. • Services-prepackaged software • California
EX-10.17 29 dex1017.htm LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • May 5th, 2020 • England
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • October 19th, 2007 • Auriga Laboratories, Inc. • Pharmaceutical preparations • New York
Agreement made this 6th day of June, 2007, between Laboratoires Carilène S.A.S a corporation existing under the laws of France, and having its principal place of business at 7, rue du Chant des Oiseaux, 78360 Montesson-France (hereinafter referred to as “Supplier”), and Auriga Laboratories, Inc., existing under the laws of the State of Delaware, U.S.A, having its principal place of business at 2029 Century Park East, Suite 1130, Los Angeles, CA 90067 U.S.A. (hereinafter referred to as “Buyer”).
Licensing and distribution agreement for colistin and ColobreatheLicensing and Distribution Agreement • April 17th, 2022
ContractLicensing and Distribution Agreement • June 18th, 2008 • Zogenix Inc • Pharmaceutical preparations • England
CERTAIN MATERIAL (INDICATED BY AN ASTERISK) HAS BEEN OMITTED FROM THIS DOCUMENT PURSUANT TO A REQUEST FOR CONFIDENTIAL TREATMENT. THE OMITTED MATERIAL HAS BEEN FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION.
LICENSING and DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • October 29th, 2007 • Bioform Medical Inc • Pharmaceutical preparations
Chemische Fabrik KREUSSLER & Co. GmbH with its registered office in 65203 Wiesbaden, Federal Republic of Germany, at Rheingaustrasse 87 - 93 (hereinafter referred to as KREUSSLER)
QuickLinks LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • May 5th, 2020 • Minnesota
THIS LICENSING AND DISTRIBUTION AGREEMENT (this "Agreement") is effective as of the 15th day of July, 1999 (the "Effective Date"), by and between GalaGen Inc., a corporation organized under the laws of the State of Delaware, with its principal place of business at 1275 Red Fox Road, Arden Hills, Minnesota 55112-6943 USA (hereinafter "GalaGen"), and American Institutional Products, Inc., a corporation organized under the laws of the State of Minnesota, with its principal place of business at 501 NE 16th Avenue, Austin, Minnesota 55912 (hereinafter "Licensee").
Industry Watch ]Licensing and Distribution Agreement • February 12th, 2009
LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • March 30th, 2005 • Jones Soda Co • Beverages • Minnesota
This Licensing and Distribution Agreement is dated effective this 16th day of July, 2004 (the “Effective Date”) by and between Jones Soda Co., a Washington corporation (“Jones”) and Target Corporation, a Minnesota corporation (“Target”).
LICENSING AND DISTRIBUTION AGREEMENT by and between BRADLEY PHARMACEUTICALS, INC. and PAR PHARMACEUTICAL, INC. DOXYCYCLINE MONOHYDRATE DECEMBER 13, 2005Licensing and Distribution Agreement • December 19th, 2005 • Bradley Pharmaceuticals Inc • Pharmaceutical preparations • New York
This LICENSING AND DISTRIBUTION AGREEMENT (this “Agreement”), dated December 13, 2005, by and between BRADLEY PHARMACEUTICALS, INC., a Delaware corporation with an address at 383 Route 46 West, Fairfield, New Jersey (“Bradley”), and PAR PHARMACEUTICAL, INC., a Delaware corporation with an address at One Ram Ridge Road, Spring Valley, New York (“Par”).
EX-10.22 12 dex1022.htm LICENSING AND DISTRIBUTION AGREEMENT CONFIDENTIALLicensing and Distribution Agreement • May 5th, 2020
Exhibit 10.22 LICENSING & DISTRIBUTION AGREEMENT by and between Parthus Technologies plc. and Silaria Corporation This DEVELOPMENT, LICENSING & DISTRIBUTION AGREEMENT with an Effective Date of September 30, 2002, is made by and between Silaria Ltd., a Republic of Ireland company doing business at Dominic Court, 41 Dominic Street, Dublin 1, Ireland (“Silaria”), and Parthus Technologies, Inc., a Republic of Ireland corporation qualified to do business in California and doing business at 32-34 Harcourt Street, Dublin 2, Ireland and at 2033 Gateway Place, Suite 150, San Jose, CA 95110 (“Licensee”). Silaria and Licensee are referred to individually as a “Party” and collectively as the “Parties.” Recitals A. Silaria designs, develops, and markets configurable microprocessor technology, in the form of semiconductor design Intellectual Property (IP). B. Licensee has developed and markets a broad portfolio of complete solutions in the form of platform-level semiconductor design Intellectual Pro
LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • December 29th, 2005 • Accentia Biopharmaceuticals Inc • Pharmaceutical preparations • Massachusetts
THIS LICENSING AND DISTRIBUTION AGREEMENT, effective as of November 22, 2005 (“Effective Date”), between Collegium Pharmaceutical, Inc., a corporation organized and existing under the laws of Delaware, with its principal offices located at 400 Highland Corporate Drive, Cumberland, R.I. 02864 (“Collegium”), and TEAMM Pharmaceuticals, Inc., an Accentia Biopharmaceuticals Company, a Florida corporation having its principal place of business at 2501 Aerial Center Parkway, Suite 100, Morrisville, NC 27560 (“TEAMM”).
LICENSING AND DISTRIBUTOR AGREEMENTLicensing and Distribution Agreement • January 23rd, 2008 • Magnum dOr Resources Inc • Metal mining
This Definitive Licensing and Distributorship Agreement entered into on this day of January 21st, 2008 by and between Artech Recyclingtechnik GmbH, (the "Company") Magnum D'Or Resources, Inc., the ("Distributorship").
LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • January 10th, 2014
LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • March 30th, 2005 • Jones Soda Co • Beverages • Ohio
This Licensing and Distribution Agreement (“Agreement”) is dated effective this first day of April, 2005 by and between Jones Soda Co., a Washington corporation (“Jones”) and The Kroger Co., an Ohio corporation, on behalf of itself and its Jackson Ice Cream division (“Kroger”).
Licensing and distribution agreement for nitroglycerin sublingual powder formulationLicensing and Distribution Agreement • July 6th, 2024
Espero Pharmaceuticals announced the signing of an exclusive Licensing and Distribution Agreement with G. Pohl-Boskamp for its new nitroglycerin sublingual powder formulation for acute relief of an attack or prophylaxis of angina pectoris for the U.S. market.
Sadowsky Licensing Distribution Agreement with WarwickLicensing and Distribution Agreement • February 27th, 2020
There has been a lot of speculation and questions on social media about the Warwick part- nership and model lines. I want to explain everything in detail so that there is no confusion.
AMENDMENT No. 5 TO LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • October 24th, 2016 • Nuo Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Amendment No. 5 to LICENSING AND DISTRIBUTION AGREEMENT (this “Amendment No. 5”) is dated as of December 31, 2014 by and between Nuo Therapeutics, Inc. (formerly Cytomedix Inc.), a Delaware corporation, with principal office at 207 Perry Parkway, Suite 1, Gaithersburg, MD 20877 (“Nuo” or “Cytomedix”) and Millennia Holdings, Inc., a California cooperation, with principal office at 3731 Wilshire Blvd., Suite 900, Los Angeles, CA 90010 (“Millennia”). Capitalized terms used in this Amendment No. 5 shall have the meanings ascribed to them in the Agreement (as defined below).
Licensing and distribution agreement for BreastCare DTS and NowCardio productsLicensing and Distribution Agreement • July 9th, 2024
Event Cardio Group has received the final $300,000 thereby completing the initial $500,000 stage of the $2,000,000 licensing agreement with MedPac Asia Pacific PTY Ltd, of Australia.
Licensing And Distribution Agreement TemplateLicensing and Distribution Agreement • September 2nd, 2021
Dluockgl-elesgsglye.dHaonwdmgillylecnongieanl iSstBefearnieawwhaernd nwuhlilliefieednaranpdt uSnhdeirswcuososdeldusMhaeysohredrowuhsiitnegnesorsmineattrtiellinotnivthe?ly LainmditrinotpohxeicRatuetsledge
LICENSING and DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • November 13th, 2019 • Marizyme Inc • Pharmaceutical preparations • Florida
This Agreement is made and entered into effective as November 1, 2019 (the “Effective Date”), by and between Somahlution, LLC, with offices located at 225 Chimney Corner Lane, Suite 2001, Jupiter, Florida 33458, a company organized and existing under the laws of Delaware (“Somahlution”), and (Marizyme, Inc.), with offices located at Davenport, Fla, the “Marizyme”.
Licensing and distribution agreement for AggrastatLicensing and Distribution Agreement • July 11th, 2024
Cardiome Pharma announced that its affiliate Correvio has entered into an exclusive license and distribution agreement with ZAO Firma Euroservice that will advance Aggrastat (tirofiban hydrochloride) toward commercialization in Russia.
Content Protection Requirements And ObligationsLicensing and Distribution Agreement • October 10th, 2024
This Schedule C is attached to and a part of that certain Licensing and Distribution Agreement, dated November __, 2012 (the “Agreement”), between/among Sony Electronics Inc. and Sony Pictures Home Entertainment Inc. All defined terms used but not otherwise defined herein shall have the meanings given them in the Agreement.
ContractLicensing and Distribution Agreement • August 15th, 2018
Mundipharma brings its cancer supportive care expertise to Vietnam after signing agreement with Helsinn Group for ALOXI® (palonosetron HCl)
Licensing and distribution agreement for C-CureLicensing and Distribution Agreement • July 8th, 2024
This license agreement confirms Celyad's intention to expand the global footprint of its lead cardiac disease cell therapy candidate for the treatment of ischemic heart failure, C-Cure.
LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • April 14th, 2022 • Point of Care Nano-Technology, Inc. • Biological products, (no disgnostic substances) • New Jersey
This Agreement is made and entered into effective as April 10, 2022 (the “Effective Date”), by and between Cedoga Consulting LLC, with offices located at 3514 Clinton Parkway, Ste A-173, Lawrence KS 66047, a company organized and existing under the laws of Kansas (“CEDOGA”), and DUO SCIENCES, INC, a subsidiary of Point of Care Nano-Technology, Inc., a Nevada corporation, with offices located in Whitehouse Station New Jersey and Davenport, Fla., (“PCNT”).
Licensing and distribution agreement for primary care productsLicensing and Distribution Agreement • August 31st, 2024
Hikma Pharmaceuticals PLC , the fast growing multinational pharmaceutical group, through its wholly-owned subsidiary Hikma Pharmaceuticals LLC has reached an agreement with Takeda Pharmaceutical Company Limited (Takeda) to expand its licensing and distribution agreement with the global research and development-driven pharmaceutical company, adding new products to its portfolio in the Middle East and North Africa (MENA).
LICENSING and DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • June 5th, 2020 • Marizyme Inc • Pharmaceutical preparations • Florida
This Agreement is made and entered into effective as April 27, 2020 (the “Effective Date”), by and between Somahlution, LLC, with offices located at 225 Chimney Corner Lane, Suite 2001, Jupiter, Florida 33458, a company organized and existing under the laws of Delaware (“Somahlution”), and Marizyme, Inc., a Nevada corporation, with offices located in Davenport, Fla., (“Marizyme”).
LICENSING AND DISTRIBUTION AGREEMENTLicensing and Distribution Agreement • May 21st, 2018 • Oi2Go Media Technologies, Inc. • Services-video tape rental • Florida
THIS A---GREEMENT, made effective as of August 14, 2017, (the "Effective Date"), by and between Oi2Go Media Technologies, Inc., with an address at 7343 W. Sand Lake Road, Unit 311, Orlando, FL 32819 (hereinafter "Licensee") and Oi2 Media Corporation with an address of business 7343 W. Sand Lake Road, Unit 311, Orlando, FL 32819 (the “Licensor.”)
